Prognostic significance of flow-cytometry evaluation of minimal residual disease in children with acute myeloid leukaemia treated according to the AIEOP-AML 2002/01 study protocol.

B Buldini, F Rizzati, R Masetti, F Fagioli, G Menna, Concetta Micalizzi, MC Putti, C Rizzari, N Santoro, M Zecca, S Disarò, R Rondelli, P Merli, M Pigazzi, A Pession, F Locatelli, G Basso

Research output: Contribution to journalArticle

Original languageEnglish
JournalBritish Journal of Haematology
Volume177
Issue number116-126
Publication statusPublished - 2017

Cite this

Buldini, B., Rizzati, F., Masetti, R., Fagioli, F., Menna, G., Micalizzi, C., Putti, MC., Rizzari, C., Santoro, N., Zecca, M., Disarò, S., Rondelli, R., Merli, P., Pigazzi, M., Pession, A., Locatelli, F., & Basso, G. (2017). Prognostic significance of flow-cytometry evaluation of minimal residual disease in children with acute myeloid leukaemia treated according to the AIEOP-AML 2002/01 study protocol. British Journal of Haematology, 177(116-126).